Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
Jia-Rong CaiFei YangXuelian ChenHe HuangBin MiaoPublished in: Pharmacogenomics and personalized medicine (2021)
These results suggest that our prognostic model may be a promising biomarker for clinical prediction of RFS in PCa patients.